Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-03 Sale | 2024-12-04 5:04 pm | Solid Biosciences Inc. | SLDB | Howton David T Chief Operating Officer | 5,072 | $5.5986 | $28,396 | 41,766 (Direct) | View |
| 2023-12-04 Sale | 2023-12-05 2:32 pm | Solid Biosciences Inc. | SLDB | Howton David T Chief Operating Officer | 5,367 | $2.78 | $14,920 | 46,838 (Direct) | View |
| 2020-06-22 Sale | 2020-06-22 9:17 pm | Sarepta Therapeutics Inc. | SRPT | Howton David T EVP, General Counsel | 105,122 | $170.88 | $17,962,831 | 39,579 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-02 Exercise | 2024-12-04 5:04 pm | N/A N/A | Solid Biosciences Inc. | SLDB | Howton David T Chief Operating Officer | 13,051 | $0 | 41,766 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-16 11:28 am | N/A 2034-02-13 | Solid Biosciences Inc. | SLDB | Howton David T Chief Operating Officer | 176,250 | $0 | 176,250 (Direct) | View |
| 2023-12-02 Exercise | 2023-12-05 2:32 pm | N/A N/A | Solid Biosciences Inc. | SLDB | Howton David T Chief Operating Officer | 13,051 | $0 | 46,838 (Direct) | View |
| 2022-12-02 Option Award | 2022-12-05 5:50 pm | N/A 2032-12-02 | Solid Biosciences Inc. | SLDB | Howton David T See Remarks | 156,615 | $0 | 156,615 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-22 9:17 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Howton David T EVP, General Counsel | 56,984 | $23.85 | 39,579 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-22 9:17 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Howton David T EVP, General Counsel | 3,138 | $13.71 | 39,579 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-22 9:17 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Howton David T EVP, General Counsel | 45,000 | $29.03 | 39,579 (Direct) | View |
| 2020-06-22 Exercise | 2020-06-22 9:17 pm | 2017-02-28 2026-02-28 | Sarepta Therapeutics Inc. | SRPT | Howton David T EVP, General Counsel | 105,122 | $0 | 39,579 (Direct) | View |
| 2020-02-28 Option Award | 2020-02-28 8:01 pm | N/A 2030-02-28 | Sarepta Therapeutics Inc. | SRPT | Howton David T EVP, General Counsel | 44,200 | $0 | 69,371 (Direct) | View |